CVC Credit Prices Fifth New CLO of 2021
CVC Credit priced Apidos XXXVII, a collateralized loan obligation fund totalling $506 million. CVC Credit has priced five CLO funds globally this year with an aggregate value of $2 billion.
CVC Credit priced Apidos XXXVII, a collateralized loan obligation fund totalling $506 million. CVC Credit has priced five CLO funds globally this year with an aggregate value of $2 billion.
CVC Credit priced Cordatus XXI, a collateralized loan obligation fund totaling €406 million ($481.1 million) and arranged by Barclays. This is the fourth CLO fund CVC Credit has priced globally this year and will take its assets under management to more than $29.5 billion.
CVC Credit priced Apidos XXXVI, a collateralized loan obligation fund totalling $508 million. This is the third new CLO fund CVC Credit has priced globally this year and will increase its assets under management to approximately $29 billion.
CVC Credit provided a debt facility to support Sole Source Capital’s acquisition of Peak-Ryzex and its subsequent add-on acquisition of Optical Phusion.
CVC Credit led an incremental $57 million multicurrency first lien credit facility for Calibre Scientific, a developer, manufacturer and distributor of consumable products in the life science tools and diagnostics markets.